BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 15 Aug 2020)
What can over 30 years of efforts to eradicate polio teach us about global health?
Authors: Olakunle Alonge
Citation: BMC Public Health 2020 20(Suppl 2):1177
Content type: Introduction
Published on: 12 August 2020
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 15 Aug 2020)
Synthesis and translation of research and innovations from polio eradication (STRIPE): initial findings from a global mixed methods study
Lessons from polio eradication efforts and the Global Polio Eradication Initiative (GPEI) are useful for improving health service delivery and outcomes globally. The Synthesis and Translation of Research and I…
Authors: Olakunle Alonge, Abigail H. Neel, Anna Kalbarczyk, Michael A. Peters, Yodi Mahendradhata, Malabika Sarker, Eme Owoaje, Wakgari Deressa, Patrick Kayembe, Ahmad Shah Salehi and S. D. Gupta
Citation: BMC Public Health 2020 20(Suppl 2):1176
Content type: Research
Published on: 12 August 2020
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 15 Aug 2020)
Synthesis and translation of research and innovations from polio eradication (STRIPE): initial findings from a global mixed methods study
Lessons from polio eradication efforts and the Global Polio Eradication Initiative (GPEI) are useful for improving health service delivery and outcomes globally. The Synthesis and Translation of Research and I…
Authors: Olakunle Alonge, Abigail H. Neel, Anna Kalbarczyk, Michael A. Peters, Yodi Mahendradhata, Malabika Sarker, Eme Owoaje, Wakgari Deressa, Patrick Kayembe, Ahmad Shah Salehi and S. D. Gupta
Citation: BMC Public Health 2020 20(Suppl 2):1176
Content type: Research
Published on: 12 August 2020
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 15 Aug 2020)
Socio-demographic correlates of first dose of measles (MCV1) vaccination coverage in India
Between 2010 and 2018, measles-related mortality had halved in India mainly with effective measles vaccination campaigns and widespread coverage across the states and population subgroups. Despite the commenda…
Authors: Basant Kumar Panda, Suyash Mishra and Niyi Awofeso
Citation: BMC Public Health 2020 20:1221
Content type: Research article
Published on: 10 August 2020
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 15 Aug 2020)
The association between protection motivation and hepatitis b vaccination intention among migrant workers in Tianjin, China: a cross-sectional study
Migrant workers are a susceptible population to the hepatitis b virus (HBV) and a vulnerable spot in China’s immunization procedures. There is no free HBV immunization program for migrant workers in China, so …
Authors: Cai Liu, Stephen Nicholas and Jian Wang
Citation: BMC Public Health 2020 20:1219
Content type: Research article
Published on: 10 August 2020
Clinical Trials
Volume 17 Issue 4, August 2020
https://journals.sagepub.com/toc/ctja/17/4
Conference Proceedings
Proceedings of the University of Pennsylvania 12th annual conference on statistical issues in clinical trials: Electronic health records (EHR) in randomized clinical trials—Challenges and opportunities
Susan S Ellenberg, Jonas H Ellenberg
First Published June 10, 2020; pp. 343–345
Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 15 Aug 2020]
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
The ongoing COVID-19 pandemic has created an urgency to identify novel vaccine targets for protective immunity against SARS-CoV-2. Early reports identify protective roles for both humoral and cell-mediated imm…
Authors: Asaf Poran, Dewi Harjanto, Matthew Malloy, Christina M. Arieta, Daniel A. Rothenberg, Divya Lenkala, Marit M. van Buuren, Terri A. Addona, Michael S. Rooney, Lakshmi Srinivasan and Richard B. Gaynor
Citation: Genome Medicine 2020 12:70
Content type: Research
Published on: 13 August 2020
International Journal of Infectious Diseases
August 2020 Volume 97, p1-404
https://www.ijidonline.com/issue/S1201-9712(20)X0009-9
Coronavirus (COVID-19) Collection
Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020
Takahiro Itaya, Yuki Furuse, Kazuaki Jindai
p78–80
Published online: June 1, 2020
International Journal of Infectious Diseases
August 2020 Volume 97, p1-404
https://www.ijidonline.com/issue/S1201-9712(20)X0009-9
What works and what does not work in response to COVID-19 prevention and control in Africa
Erigene Rutayisire, Gerard Nkundimana, Honore K. Mitonga, Alex Boye, Solange Nikwigize
p267–269
Published online: June 11, 2020
JAMA Network
COVID-19 Update August 15, 2020
These articles on COVID-19 were published across the JAMA Network in the last week.
JAMA
August 11, 2020, Vol 324, No. 6, Pages 529-614
https://jamanetwork.com/journals/jama/currentissue
COVID-19: Beyond Tomorrow
The Work of Philanthropy in Responding to COVID-19 and Addressing InequalityA New Foundation
Darren Walker, JD
free access has active quiz has multimedia has audio
JAMA. 2020;324(6):541-542. doi:10.1001/jama.2020.12904
In this Viewpoint the president of the Ford Foundation calls on philanthropic and other wealthy organizations to make creative and generous grants to less well-endowed counterpart institutions and communities to redress the racial and socioeconomic disparities exposed by the COVID-19 pandemic and continued killings of Black Americans.
JAMA
August 11, 2020, Vol 324, No. 6, Pages 529-614
https://jamanetwork.com/journals/jama/currentissue
Pooling Data From Individual Clinical Trials in the COVID-19 Era
Eva Petkova, PhD; Elliott M. Antman, MD; Andrea B. Troxel, ScD
free access has active quiz
JAMA. 2020;324(6):543-545. doi:10.1001/jama.2020.13042
This Viewpoint proposes principles and processes to allow pooling of individual patient data from clinical trials given decelerating participant recruitment at sites where the COVID-19 surge has been controlled and new cases are diminishing.
JAMA
August 11, 2020, Vol 324, No. 6, Pages 529-614
https://jamanetwork.com/journals/jama/currentissue
The Advisory Committee on Immunization Practices and Its Role in the Pandemic Vaccine Response
Grace M. Lee, MD, MPH; Beth P. Bell, MD, MPH; José R. Romero, MD
free access has active quiz
JAMA. 2020;324(6):546-547. doi:10.1001/jama.2020.13167
This Viewpoint discusses the role of the Advisory Committee on Immunization Practices, a federal advisory committee that makes vaccine-related recommendations to the CDC and DHHS, in guiding the development and deployment of COVID-19 vaccines.
JAMA
August 11, 2020, Vol 324, No. 6, Pages 529-614
https://jamanetwork.com/journals/jama/currentissue
COVID-19 Response in Lebanon – Current Experience and Challenges in a Low-Resource Setting
Petra Khoury, PharmD; Eid Azar, MD; Eveline Hitti, MD, MBA
free access has active quiz
JAMA. 2020;324(6):548-549. doi:10.1001/jama.2020.12695
This Viewpoint describes the unique challenges faced by Lebanon, a small densely populated country with a fragmented health care system, in its response to the emerging COVID-19 pandemic, and it summarizes organizational, testing, and communications policies the nation has implemented that might be useful to other resource-limited countries and settings.
Journal of Evidence-Based Medicine
Volume 13, Issue 3 Pages: 179-249 August 2020
https://onlinelibrary.wiley.com/toc/17565391/current
COMMENTARY
Are randomized controlled trials being conducted with the right justification?
Corbin Walters, Trevor Torgerson, Ian Fladie, Angela Clifton, Chase Meyer, Matt Vassar
Pages: 181-182
First Published: 02 July 2020
Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 15 Aug 2020]
Articles
Registration and local production of essential medicines in Uganda
Authors: Petra Brhlikova, Karen Maigetter, Jude Murison, Amon G. Agaba, Jonans Tusiimire and Allyson M. Pollock
Content type: Research
11 August 2020
The Lancet
Aug 15, 2020 Volume 396 Number 10249 p447-512
https://www.thelancet.com/journals/lancet/issue/current
Editorial
Humanitarian crises in a global pandemic
The Lancet
The Lancet
Aug 15, 2020 Volume 396 Number 10249 p447-512
https://www.thelancet.com/journals/lancet/issue/current
Comment
The Lancet COVID-19 Commission
Jeffrey D Sachs, Richard Horton, ey al
[See Milestones above for detail]
The Lancet
Aug 15, 2020 Volume 396 Number 10249 p447-512
https://www.thelancet.com/journals/lancet/issue/current
Articles
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M Folegatti, et al on behalf of the Oxford COVID Vaccine Trial Group
The Lancet
Aug 15, 2020 Volume 396 Number 10249 p447-512
https://www.thelancet.com/journals/lancet/issue/current
Nature
Volume 584 Issue 7820, 13 August 2020
http://www.nature.com/nature/current_issue.html
Editorial | 12 August 2020
How to stop COVID-19 fuelling a resurgence of AIDS, malaria and tuberculosis
A focus on the coronavirus has disrupted detection and treatment of other infectious diseases. Governments and funders can do four things to avert a catastrophe.
Nature Medicine
Volume 26 Issue 8, August 2020
https://www.nature.com/nm/volumes/26/issues/8
Focus on COVID-19 and digital privacy
The COVID-19 pandemic has necessitated the acceleration of the development of digital technologies to monitor the spread of the outbreak. Emergency powers are being used to track not just individuals’ health data, but other personal information. The image shows the data that are being monitored on people’s cell phones, and the effects on healthcare are discussed in this focus issue on COVID-19 and digital privacy.
Nature Medicine
Volume 26 Issue 8, August 2020
https://www.nature.com/nm/volumes/26/issues/8
Editorial | 07 August 2020
Build trust in digital health
The rapid rollout of digital health approaches in the ongoing global COVID-19 pandemic has neglected to prioritize data privacy and is a missed opportunity for building users’ trust in these technologies for future outbreaks and quotidian healthcare.
Nature Medicine
Volume 26 Issue 8, August 2020
https://www.nature.com/nm/volumes/26/issues/8
Comment | 02 June 2020
Building an international consortium for tracking coronavirus health status
We call upon the research community to standardize efforts to use daily self-reported data about COVID-19 symptoms in the response to the pandemic and to form a collaborative consortium to maximize global gain while protecting participant privacy.
Eran Segal, Feng Zhang[…] & Paul Wilmes
Nature Medicine
Volume 26 Issue 8, August 2020
https://www.nature.com/nm/volumes/26/issues/8
Comment | 26 May 2020
Use of apps in the COVID-19 response and the loss of privacy protection
Mobile apps provide a convenient source of tracking and data collection to fight against the spread of COVID-19. We report our analysis of 50 COVID-19-related apps, including their use and their access to personally identifiable information, to ensure that the right to privacy and civil liberties are protected.
Tanusree Sharma & Masooda Bashir
Nature Medicine
Volume 26 Issue 8, August 2020
https://www.nature.com/nm/volumes/26/issues/8
Comment | 26 May 2020
Mass-surveillance technologies to fight coronavirus spread: the case of Israel
As the COVID-19 pandemic escalates, teams around the world are now advocating for a new approach to monitoring transmission: tapping into cellphone location data to track infection spread and warn people who may have been exposed. Here we present data collected in Israel through this approach so far and discuss the privacy concerns, alternatives and different ‘flavors’ of cellphone surveillance. We also propose safeguards needed to minimize the risk for civil rights.
Moran Amit, Heli Kimhi[…] & Avi Benov
Nature Medicine
Volume 26 Issue 8, August 2020
https://www.nature.com/nm/volumes/26/issues/8
Perspective | 07 August 2020
Regulatory, safety, and privacy concerns of home monitoring technologies during COVID-19
Home monitoring technologies are being rushed to market during the COVID-19 pandemic; here, safety and privacy considerations are discussed.
Sara Gerke, Carmel Shachar[…] & I. Glenn Cohen
Nature Medicine
Volume 26 Issue 8, August 2020
https://www.nature.com/nm/volumes/26/issues/8
Review Article | 07 August 2020
Digital technologies in the public-health response to COVID-19
The COVID-19 pandemic has resulted in an accelerated development of applications for digital health, including symptom monitoring and contact tracing. Their potential is wide ranging and must be integrated into conventional approaches to public health for best effect.
Jobie Budd, Benjamin S. Miller[…] & Rachel A. McKendry
New England Journal of Medicine
August 13, 2020 Vol. 383 No. 7
http://www.nejm.org/toc/nejm/medical-journal
Perspective
Hepatitis C Treatment in Prisons — Incarcerated People’s Uncertain Right to Direct-Acting Antiviral Therapy A.M. Daniels and D.M. Studdert
New England Journal of Medicine
August 13, 2020 Vol. 383 No. 7
http://www.nejm.org/toc/nejm/medical-journal
PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 15 Aug 2020)
Diagnosis of neglected tropical diseases during and after the COVID-19 pandemic
Dziedzom K. de Souza, Albert Picado, Sylvain Biéler, Sarah Nogaro, Joseph Mathu Ndung’u
Viewpoints | published 14 Aug 2020 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0008587
PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 15 Aug 2020)
Simultaneous dengue and COVID-19 epidemics: Difficult days ahead?
Mathieu Nacher, Maylis Douine, Mélanie Gaillet, Claude Flamand, Dominique Rousset, Cyril Rousseau, Chedli Mahdaoui, Stanley Carroll, Audrey Valdes, Nathalie Passard, Gabriel Carles, Félix Djossou, Magalie Demar, Loïc Epelboin
Viewpoints | published 14 Aug 2020 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0008426
PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 15 Aug 2020)
The process of building the priority of neglected tropical diseases: A global policy analysis
Nathaly Aya Pastrana, David Beran, Claire Somerville, Olivia Heller, Jorge C. Correia, L. Suzanne Suggs
Research Article | published 12 Aug 2020 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0008498
PLoS One
http://www.plosone.org/
Comparing catch-up vaccination programs based on analysis of 2012–13 rubella outbreak in Kawasaki City, Japan
Chiyori T. Urabe, Gouhei Tanaka, Takahiro Oshima, Aya Maruyama, Takako Misaki, Nobuhiko Okabe, Kazuyuki Aihara
Research Article | published 14 Aug 2020 PLOS ONE
https://doi.org/10.1371/journal.pone.0237312
PLoS One
http://www.plosone.org/
Vaccination discourses among chiropractors, naturopaths and homeopaths: A qualitative content analysis of academic literature and Canadian organizational webpages
Eric Filice, Eve Dubé, Janice E. Graham, Noni E. MacDonald, Julie A. Bettinger, Devon Greyson, Shannon MacDonald, S. Michelle Driedger, Greg Kawchuk, Samantha B. Meyer
Research Article | published 12 Aug 2020 PLOS ONE
https://doi.org/10.1371/journal.pone.0236691
PLoS One
http://www.plosone.org/
Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
Margaret J. de Villiers, Ivane Gamkrelidze, Timothy B. Hallett, Shevanthi Nayagam, Homie Razavi, Devin Razavi-Shearer
Research Article | published 10 Aug 2020 PLOS ONE
https://doi.org/10.1371/journal.pone.0237525
PLoS Pathogens
http://journals.plos.org/plospathogens/
[Accessed 15 Aug 2020]
No more business as usual: Agile and effective responses to emerging pathogen threats require open data and open analytics
Dannon Baker, Marius van den Beek, Daniel Blankenberg, Dave Bouvier, John Chilton, Nate Coraor, Frederik Coppens, Ignacio Eguinoa, Simon Gladman, Björn Grüning, Nicholas Keener, Delphine Larivière, Andrew Lonie, Sergei Kosakovsky Pond, Wolfgang Maier, Anton Nekrutenko, James Taylor, Steven Weaver
Opinion | published 13 Aug 2020 PLOS Pathogens
https://doi.org/10.1371/journal.ppat.1008643
Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
https://www.paho.org/journal/en
14 Aug 2020
A COVID-19 opportunity: Applying a systems approach to food security and noncommunicable diseases
Letter | English |
Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
https://www.paho.org/journal/en
Latest articles
14 Aug 2020
Use of point-of-care technologies for the management of the COVID-19 pandemic in Colombia
Special report | Spanish |
Science
14 August 2020 Vol 369, Issue 6505
http://www.sciencemag.org/current.dtl
Editorial
Vaccine nationalism’s politics
By David P. Fidler
Science14 Aug 2020
Before coronavirus disease 2019 (COVID-19) struck, cooperation on global health—especially for pandemic preparedness and response—would, we told ourselves, enhance national security, support economic wealth, protect human rights, and facilitate humanitarian assistance around the world. However, the politics of the coronavirus catastrophe do not reflect such national interests or international solidarity. “Vaccine nationalism” is more evidence that efforts to elevate health cooperation—and the sciences that inform it—have produced more rhetoric than political roots within countries and the international community.
Concerns about vaccine nationalism were escalating even before the United States announced on 31 July its largest deal to date with pharmaceutical companies to secure COVID-19 vaccines. Other countries—including China, India, the United Kingdom, and members of the European Union—are pursuing similar strategies. To critics, this scramble to secure vaccine supplies is one of many decisions by governments that have failed to control spread of the virus, destroyed economic activity, and damaged international cooperation. Ineffective nationalistic policies appear to create a gap between science and politics that makes the pandemic worse and undermines what science and health diplomacy could achieve. In fact, vaccine nationalism reflects “business as usual” in global health.
Historically, health diplomacy has struggled with global, equitable access to drugs and vaccines during serious disease events. Countries did not achieve this goal, for example, during the 2009 H1N1 influenza pandemic. International access typically happened only after developed countries secured pharmaceuticals for use at home, as happened with vaccines for smallpox and polio and drugs for HIV/AIDS. Developing countries, such as China and India, tried to break out of this pattern by building their own pharmaceutical innovation and production capabilities. More recently, developing countries have asserted sovereignty over pathogenic samples. This approach conditions access to samples on the source country receiving benefits from research and development, including drugs and vaccines. This “viral sovereignty” strategy produced the virus-and-benefit sharing regime in the World Health Organization’s Pandemic Influenza Preparedness Framework in 2011.
With COVID-19, history is repeating itself. Countries with the resources to obtain vaccines have not subordinated their needs and capacities to the objective of global, equitable access. And the worldwide spread of the coronavirus eliminates leverage that viral sovereignty might have provided countries without such means. International and nongovernmental organizations launched an ad hoc effort—the COVID-19 Vaccines Global Access (COVAX) Facility—to achieve equitable access. But with no serious participation by major states so far, COVAX lacks game-changing support. In keeping with the longstanding pattern of political behavior during pandemics, vaccines will eventually reach most populations, but only after powerful countries have protected themselves.
Further, changes in domestic and global politics have made matters worse. Domestically, the extent to which governments have ignored science, denigrated health experts, supported quack remedies and policies, peddled disinformation, and botched social distancing and other nonpharmaceutical interventions has been astonishing. This travesty flows from the traction that populist, nationalist, antiglobalist, and authoritarian attitudes have gained around the world.
Globally, balance-of-power politics has returned to world affairs. Geopolitical calculations have shaped national responses to COVID-19, with the United States and China treating the pandemic as another front in their rivalry for power and influence. National access to coronavirus vaccines has become a priority in power politics, especially as a means to recover from the economic damage at home, in export markets, and within regions of strategic importance in the balance of power.
These changes in politics have generated ferocious headwinds against global, equitable vaccine access—an objective only approached with great difficulty when political waters were less turbulent. Reorienting health policy and diplomacy will require root-and-branch reconstruction of political interests on infectious diseases. Perhaps the mounting desperation for scientists to deliver a vaccine against COVID-19 will provide an incentive for leaders to rebuild health policies sufficiently so that, when the next pandemic hits, politicians and citizens will be less likely to drink the hydroxychloroquine.
Science
14 August 2020 Vol 369, Issue 6505
http://www.sciencemag.org/current.dtl
In Depth
Antibodies may curb pandemic before vaccines
By Jon Cohen
Science14 Aug 2020 : 752-753 Full Access
Now in efficacy trials, monoclonal antibodies promise to both prevent and treat disease.
Science
14 August 2020 Vol 369, Issue 6505
http://www.sciencemag.org/current.dtl
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
By Jingyou Yu, Lisa H. Tostanoski, Lauren Peter, Noe B. Mercado, Katherine McMahan, Shant H. Mahrokhian, Joseph P. Nkolola, Jinyan Liu, Zhenfeng Li, Abishek Chandrashekar, David R. Martinez, Carolin Loos, Caroline Atyeo, Stephanie Fischinger, John S. Burke, Matthew D. Slein, Yuezhou Chen, Adam Zuiani, Felipe J. N. Lelis, Meghan Travers, Shaghayegh Habibi, Laurent Pessaint, Alex Van Ry, Kelvin Blade, Renita Brown, Anthony Cook, Brad Finneyfrock, Alan Dodson, Elyse Teow, Jason Velasco, Roland Zahn, Frank Wegmann, Esther A. Bondzie, Gabriel Dagotto, Makda S. Gebre, Xuan He, Catherine Jacob-Dolan, Marinela Kirilova, Nicole Kordana, Zijin Lin, Lori F. Maxfield, Felix Nampanya, Ramya Nityanandam, John D. Ventura, Huahua Wan, Yongfei Cai, Bing Chen, Aaron G. Schmidt, Duane R. Wesemann, Ralph S. Baric, Galit Alter, Hanne Andersen, Mark G. Lewis, Dan H. Barouch
Science14 Aug 2020 : 806-811 Open Access
Successful protection against SARS-CoV-2 in rhesus macaques by means of a prototype DNA vaccine is described.
Science
14 August 2020 Vol 369, Issue 6505
http://www.sciencemag.org/current.dtl
Reports
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
By Wei Deng, Linlin Bao, Jiangning Liu, Chong Xiao, Jiayi Liu, Jing Xue, Qi Lv, Feifei Qi, Hong Gao, Pin Yu, Yanfeng Xu, Yajin Qu, Fengdi Li, Zhiguang Xiang, Haisheng Yu, Shuran Gong, Mingya Liu, Guanpeng Wang, Shunyi Wang, Zhiqi Song, Ying Liu, Wenjie Zhao, Yunlin Han, Linna Zhao, Xing Liu, Qiang Wei, Chuan Qin
Science14 Aug 2020 : 818-823 Open Access
SARS-CoV-2 infection was able to induce robust protective immunity against reexposure to virus in nonhuman primates.
Science
14 August 2020 Vol 369, Issue 6505
http://www.sciencemag.org/current.dtl
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
By Abishek Chandrashekar, Jinyan Liu, Amanda J. Martinot, Katherine McMahan, Noe B. Mercado, Lauren Peter, Lisa H. Tostanoski, Jingyou Yu, Zoltan Maliga, Michael Nekorchuk, Kathleen Busman-Sahay, Margaret Terry, Linda M. Wrijil, Sarah Ducat, David R. Martinez, Caroline Atyeo, Stephanie Fischinger, John S. Burke, Matthew D. Slein, Laurent Pessaint, Alex Van Ry, Jack Greenhouse, Tammy Taylor, Kelvin Blade, Anthony Cook, Brad Finneyfrock, Renita Brown, Elyse Teow, Jason Velasco, Roland Zahn, Frank Wegmann, Peter Abbink, Esther A. Bondzie, Gabriel Dagotto, Makda S. Gebre, Xuan He, Catherine Jacob-Dolan, Nicole Kordana, Zhenfeng Li, Michelle A. Lifton, Shant H. Mahrokhian, Lori F. Maxfield, Ramya Nityanandam, Joseph P. Nkolola, Aaron G. Schmidt, Andrew D. Miller, Ralph S. Baric, Galit Alter, Peter K. Sorger, Jacob D. Estes, Hanne Andersen, Mark G. Lewis, Dan H. Barouch
Science
14 August 2020 Vol 369, Issue 6505
http://www.sciencemag.org/current.dtl
A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2
By Tom Britton, Frank Ball, Pieter Trapman
Science14 Aug 2020 : 846-849 Open Access
Human population heterogeneities bring down estimates for herd immunity.
Vaccine
Volume 38, Issue 36 Pages 5741-5876 (10 August 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/36
Review article Open access
Implementation of the United Kingdom’s childhood influenza national vaccination programme: A review of clinical impact and lessons learned over six influenza seasons
George Kassianos, Pauline MacDonald, Ivan Aloysius, Arlene Reynolds
Vaccine
Volume 38, Issue 36 Pages 5741-5876 (10 August 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/36
Research article Abstract only
Impact of a decision-aid tool on influenza vaccine coverage among HCW in two French hospitals: A cluster-randomized trial
Florian Saunier, Philippe Berthelot, Benoît Mottet-Auselo, Carole Pelissier, … Amandine Gagneux-Brunon
Pages 5759-5763
Vaccine
Volume 38, Issue 36 Pages 5741-5876 (10 August 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/36
Research article Abstract only
Spread of vaccine hesitancy in France: What about YouTube™?
Marin Lahouati, Antoine De Coucy, Jean Sarlangue, Charles Cazanave
Pages 5779-5782
Vaccine
Volume 38, Issue 36 Pages 5741-5876 (10 August 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/36
Research article Open access
Two decades of vaccine innovations for global public good: Report of the Developing Countries’ Vaccine Manufacturers Network 20th meeting, 21–23 october 2019, Rio de Janeiro, Brazil
Sonia Pagliusi, Maureen Dennehy, Akira Homma
Pages 5851-5860
Vaccine
Volume 38, Issue 36 Pages 5741-5876 (10 August 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/36
Research article Open access
A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations
Shainoor J. Ismail, Kendra Hardy, Matthew C. Tunis, Kelsey Young, … Caroline Quach
Pages 5861-5876
vaccines and global health :: ethics and policy 